Find all the latest on acute myeloid leukemia at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
Maintenance treatment for patients with acute myeloid leukemia (AML) in remission has recently been controversially discussed and even abandoned by several groups. An analysis of 16 published multicenter trials, however, revealed the highest probabilities of relapse free survival (RFS) in the range of...
Acute Myeloid Leukemia (AML) is a bone marrow malignancy characterized by the infiltration of the bone marrow, blood and other tissues by clonal cells of the myeloid lineage with limited or no potential for differentiation [1]. From: Leukemia Research, 2022 ...
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy primarily driven by an immature population of AML cells termed leukemia stem cells (LSCs) that are implicated in AML development, chemoresistance, and relapse. An emerging area of research in AML focuses on identifying and targetin...
Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study 2024, Leukemia Research Citation Excerpt : See supplementary material for confusion matrices. The use of AI in AML has become inescapable [30,31], as we have to deal with a ...
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML) is occurring rapidly. Since 2017, nine agents have been approved for various indications in AML. These included several targeted therapies like venetoclax, FLT3 inhi
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The"Acute Myeloid Leukemia (AML) in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction"report has been added toResearchAndMarkets.com'soffering. This 45-page rep...
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. While survival for younger patients over the last several decades has improved nearly sixfold with the optimization of intensive induction chemotherapy and allogeneic stem cell tra
Researchers have revealed new insights into how acute myeloid leukemia (AML) develops and progresses, according to a study published in Molecular Cell on July 20, 2021. They describe a mechanism by which AML cells regulate a cancer-related protein, mutan
Acute Leukemia and Myelodysplasia: Advances and Controversies Craig T.Jordan, inBest Practice & Research Clinical Haematology, 2019 Abstract De novo acute myeloid leukemia(AML) leukemia stem cell (LSC) populations are uniquely dependent on amino acid metabolism to drive the TCA cycle and oxidative ph...